Cargando…

Chromatin Phenotype Karyometry Can Predict Recurrence in Papillary Urothelial Neoplasms of Low Malignant Potential

Background: A preceding exploratory study (J. Clin. Pathol. 57(2004), 1201–1207) had shown that a karyometric assessment of nuclei from papillary urothelial neoplasms of low malignant potential (PUNLMP) revealed subtle differences in phenotype which correlated with recurrence of disease. Aim of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montironi, Rodolfo, Scarpelli, Marina, Lopez-Beltran, Antonio, Mazzucchelli, Roberta, Alberts, David, Ranger-Moore, James, Bartels, Hubert G., Hamilton, Peter W., Einspahr, Janine, Bartels, Peter H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2007
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617991/ https://www.ncbi.nlm.nih.gov/pubmed/17429141 http://dx.doi.org/10.1155/2007/356464

Ejemplares similares

Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma
por: Zizzi, Antonio, et al.
Publicado: (2013)

DNA Karyometry for Automated Detection of Cancer Cells
por: Böcking, Alfred, et al.
Publicado: (2022)

How much do you know about benign, preneoplastic, non-invasive and invasive neoplastic lesions of the urinary bladder classified according to the 2004 WHO scheme?
por: Montironi, Rodolfo, et al.
Publicado: (2011)

Handling of Radical Prostatectomy Specimens: Total Embedding with Large-Format Histology
por: Montironi, Rodolfo, et al.
Publicado: (2012)

Automated detection of cancer cells in effusion specimens by DNA karyometry
por: Böcking, Alfred H., et al.
Publicado: (2018)

Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy
por: Mazzucchelli, Roberta, et al.
Publicado: (2007)

Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma
por: Galosi, Andrea B, et al.
Publicado: (2014)

Does prostate acinar adenocarcinoma with Gleason Score 3 + 3 = 6 have the potential to metastasize?
por: Montironi, Rodolfo, et al.
Publicado: (2014)

Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
por: Montironi, Rodolfo, et al.
Publicado: (2021)

Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Immunohistochemical Expression and Localization of Somatostatin Receptor Subtypes in Androgen Ablated Prostate Cancer
por: Mazzucchelli, Roberta, et al.
Publicado: (2010)

Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter
por: Bianconi, Maristella, et al.
Publicado: (2019)

Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression
por: Cimadamore, Alessia, et al.
Publicado: (2017)

Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians
por: Gasparrini, Silvia, et al.
Publicado: (2019)

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
por: Aurilio, Gaetano, et al.
Publicado: (2020)

Low-grade papillary urothelial neoplasm: A case report study
por: Binsaeedu, Abdullah S., et al.
Publicado: (2023)

Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers
por: Santoni, Matteo, et al.
Publicado: (2019)

TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?—a narrative review
por: Rizzo, Alessandro, et al.
Publicado: (2021)

A Case of Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) in Childhood
por: Abbasion, Reza, et al.
Publicado: (2020)

Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis
por: Lopez-Beltran, Antonio, et al.
Publicado: (2021)

Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC)
por: Kim, Jung Kwon, et al.
Publicado: (2017)

Uropathologists During the COVID-19 Pandemic: What Can Be Learned in Terms of Social Interaction, Visibility, and Social Distance
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Digital diagnostics and artificial intelligence in prostate cancer treatment in 5 years from now
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Update on Prostate Cancer Diagnosis, Prognosis, and Prediction to Response to Therapy
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Lesson from the COVID-19 pandemic: pathologists need to build their confidence on working in a digital microscopy environment
por: Montironi, Rodolfo, et al.
Publicado: (2021)

Bladder Cancer Sample Handling and Reporting: Pathologist's Point of View
por: Mazzucchelli, Roberta, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing
por: Lopez-Beltran, Antonio, et al.
Publicado: (2021)

Usefulness of pT1 substaging in papillary urothelial bladder carcinoma
por: Patriarca, Carlo, et al.
Publicado: (2016)

Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRɑ) signal through MAPK/ERK pathway in human prostate tissues: A morphological and biomolecular study
por: Fantone, Sonia, et al.
Publicado: (2020)

Synchronous Renal Neoplasm: Clear Cell Renal Cell Carcinoma and Papillary Urothelial Carcinoma in the Same Kidney
por: Benavides-Huerto, Miguel Armando, et al.
Publicado: (2017)

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma
por: Mollica, Veronica, et al.
Publicado: (2020)

Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth
por: Maxwell, Jay P, et al.
Publicado: (2015)

Gallbladder papillary neoplasms share pathological features with intraductal papillary neoplasm of the bile duct
por: Wan, Xueshuai, et al.
Publicado: (2017)

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Microbiome and Cancers, With Focus on Genitourinary Tumors
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
por: Lopez-Beltran, Antonio, et al.
Publicado: (2021)

Role of Cytokeratin 20 as a Predictive and Prognostic Marker in Urothelial Neoplasms
por: Popov, Hristo, et al.
Publicado: (2022)

Relapsed papillary urothelial neoplasm of low malignant potential (PUNLMP) of the young age: a case report and a review of the literature
por: Maurizi, Palma, et al.
Publicado: (2019)

Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification
por: Montes-Mojarro, Ivonne A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_89jngsp05chfuoeu5f6sneb3ds